MOESM1 of The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility

MLA

Watanabe, Susan, et al. MOESM1 of The HIV-1 Late Domain-2 S40A Polymorphism in Antiretroviral (or ART)-Exposed Individuals Influences Protease Inhibitor Susceptibility. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ccf5117a5781a17d198eaf5f918788df&authtype=sso&custid=ns315887. Accessed 14 Dec. 2024.

APA

Watanabe, S., Simon, V., Durham, N., Kemp, B., Machihara, S., Kimdar Kemal, Binshan Shi, Foley, B., Hongru Li, Chen, B., Weiser, B., Burger, H., Anastos, K., Chaoping Chen, & Carter, C. (n.d.). MOESM1 of The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility.

Chicago

Watanabe, Susan, Viviana Simon, Natasha Durham, Brittney Kemp, Satoshi Machihara, Kimdar Kemal, Binshan Shi, et al. 2024. “MOESM1 of The HIV-1 Late Domain-2 S40A Polymorphism in Antiretroviral (or ART)-Exposed Individuals Influences Protease Inhibitor Susceptibility.” Accessed December 14. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ccf5117a5781a17d198eaf5f918788df&authtype=sso&custid=ns315887.